Announcements - OBI Pharma 台灣浩鼎

2020.Mar.13

Board of Directors approved the Company’s 2019 financial statement

2020.Mar.12

Clarification on News Article by Economy Daily News

2020.Mar.05

OBI Pharma Inc. to attend Investor Conference hosted by Masterlink Securities

2020.Jan.21

Announcement of the U.S. FDA approval on Orphan Drug Designation of Globo H antibody drug conjugate, OBI-999, targeting Gastric Cancer

2020.Jan.08

OBI Pharma Inc. to attend The 38th Annual J.P. Morgan Healthcare Conference

2019.Dec.24

Announcement of the U.S. FDA approval on Orphan Drug Designation of Globo H antibody drug conjugate, OBI-999, targeting Pancreatic Cancer

2019.Dec.20

Supplementary statement regarding the news article by Economy Daily News

2019.Nov.28

Board of Directors Agreed Subsidiary OBI Pharma (Shanghai) Limited to Implement Partial Intellectual Property Rights of Headquarter – Rights in China

2019.Nov.28

Announcement on Change of General Manager

2019.Nov.26

Clarification on news articles

News

Latest news

Events

Latest events